What topics would you like to see discussed during a live Facebook chat?
by Multiple Myeloma Research Foundation - MMRF
In a Facebook poll of 43 respondents, 25.6% chose “Symptom Management”. How we count
Symptom Management
25.6%11
Clinical Trials
23.3%10
Immunotherapy
23.3%10
Patient Support
18.6%8
CoMMpass Study Updates
4.7%2
Will Revlimid be coming off patent soon and have a price reduction?
2.3%1
Elderly patients with mm
2.3%1
side effects
0%0
Pain Management
0%0
Share: ···